Angelini Pharma
↗Rome, Italy
Angelini Pharma is the pharmaceutical division of the privately-owned Italian industrial group, Angelini Industries. The company is an integrated pharmaceutical entity that researches, develops, and commercializes health solutions, with a primary strategic focus on Brain Health (including mental health and epilepsy), Specialty & Primary Care, and Consumer Healthcare.
With a history spanning over 100 years, Angelini Pharma operates internationally across 20 countries, maintaining robust R&D programs and world-class manufacturing facilities in Italy, Portugal, and Turkey. The company actively expands its portfolio through a combination of internal R&D, strategic in-licensing, and acquisitions, such as the acquisition of Arvelle Therapeutics to bolster its epilepsy franchise.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:CNS therapeutics, Consumer Healthcare
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1B-$2B
Founded:1919
Ownership:private
Status:operating
PIPELINE
Stage:Phase 3
Lead Drug Stage:Commercial (Cenobamate/Ontozry)
Modalities:Small molecule, Antisense oligonucleotides, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:1
CORPORATE STRUCTURE
Parent Company:Angelini Industries
Subsidiaries:Angelini Pharma Inc. (USA), Angelini Pharma Zug S.p.A. (Switzerland)
Key Partnerships:Sovargen (SVG105 development), GRIN Therapeutics (radiprodil), OmniAb (RO'599 program), Cureverse (Nrf2-targeting compound), JCR Pharmaceuticals (blood-brain barrier technology)
COMPETITION
Position:Challenger
Competitors:UCB, Lundbeck, Recordati, Menarini Group
LEADERSHIP
Key Executives:
Sergio Marullo di Condojanni - CEO
LINKS
Website:angelinipharma.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Angelini Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Angelini Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.